Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 and Chilblains
- Status
- COMPLETED
- Phase
- NA
Inflammatory Regulation Effect of NAC on COVID-19 Treatment
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Hexoskin Feasibility Study With COVID-19 Patients
- Status
- WITHDRAWN
- Phase
- N/A
The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications
- Status
- UNKNOWN
- Phase
- N/A
Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.
- Status
- COMPLETED
- Phase
- N/A
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
- Status
- UNKNOWN
- Phase
- PHASE3
Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)
- Status
- UNKNOWN
- Phase
- N/A
Acceptability of Telehealth Triage Using Robotic Systems in COVID-19
- Status
- COMPLETED
- Phase
- N/A
VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
- Status
- COMPLETED
- Phase
- PHASE2
Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19
- Status
- COMPLETED
- Phase
- N/A
Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Safety and Efficacy of C21 in Subjects With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients
- Status
- UNKNOWN
- Phase
- NA